Haemostatic changes in tall girls treated with high doses of ethinyloestradiol

Eur J Pediatr. 1980 Sep;134(3):245-8. doi: 10.1007/BF00441480.

Abstract

Haemostasis was studied in 8 tall girls during treatment with high doses of synthetic oestrogens for a period of 1 to 28 months. The girls received 0.5 mg ethinyloestradiol daily from day 1 to day 25 and 15 mg norethisteron daily from day 21 to day 25. All were without clinical signs of thromboembolism. Factors of the prothrobmin complex were significantly elevated in the tall girls compared to healthy controls of the same age. Fibrinogen was also significantly elevated. Factor VIII-related antigen was significantly higher in the tall girls and the ratio between factor VIII activity and factor VIII-related antigen was significantly decreased in the tall girls, as compared to the controls. Thrombin time was significantly shortened. Tests of primary haemostasis showed an increased tendency for thrombocytes to adhere to glass and to aggregate spontaneously and after stimulation with ADP or collagen. Whether these in vitro signs of hypercoagulability indicate an enhanced risk of throbmoembolic complications in tall girls treated with high doses of oestrogens remains to be established. However, these girls should be watched carefully for clinical signs of throbmoembolic complications during treatment.

PIP: 8 tall girls were studied during treatment with high doses of synthetic estrogen for from 1-28 months to determine effects on hemostasis. Doses of .5 mg of ethinylestradiol were given daily from Day 1-25 and of 15 mg of norethisterone daily from Day 21-25 to the girls, all of whom had no clinical signs of thromboembolism. Blood coagulation factors were determined. Factors of prothrombin complex were elevated significantly in the tall girls compared with healthy controls of normal height of the same age. Factor VII-related antigen was significantly higher in tall girls, and the ratio of Factor VIII activity and Factor VII-related antigen was significantly decreased in tall girls compared with normal controls. Fibrinogen was also significantly elevated in tall girls. Thrombin time was shortened significantly. Primary hemostasis tests showed increased tendency for thrombocytes to adhere to glass and to aggregate spontaneously after stimulation with ADP or collagen. The relationship between increased risk of blood coagulation abnormalities and these in vitro findings remains to be established, but tall girls should be carefully observed for clinical signs of thromboembolic complications if under treatment with steroid preparations.

MeSH terms

  • Adolescent
  • Blood Coagulation*
  • Body Height
  • Ethinyl Estradiol / therapeutic use*
  • Factor VIII / analysis
  • Female
  • Fibrinogen / analysis
  • Growth Disorders / drug therapy*
  • Humans
  • Norethindrone / therapeutic use
  • Platelet Adhesiveness
  • Thrombin Time

Substances

  • Ethinyl Estradiol
  • Factor VIII
  • Fibrinogen
  • Norethindrone